Introduction
It is the dream of many neurobiologists to understand the basic electrophysiological and biochemical properties of our memory. Since Donald Hebb's groundbreaking theory on the principles of learning (1949) , neurobiologists largely agree that the contents of our memory are represented in our brains by facilitated transmissions of synaptic signals within neuronal networks. To allow such a memory trace to manifest itself in the neuronal network, the connecting synapses (glutamatergic, excitatory synapses, and GABAergic, inhibitory synapses) need to be plastic. This means that they must possess the flexibility to be regulated in both directions (i.e., augmented or attenuated) depending on the strength and frequency of their usage, the history of their activation, and the efficiency of their signal transmission. Further groundbreaking discoveries by Bliss and Lomo in 1972 [1] established long-term potentiation (LTP) at high frequency stimulated synapses as a model for the investigation of memory-related increases in synaptic efficiency.
Neuromodulatory transmitters (such as dopamine and noradrenaline) and secreted neuropeptides such as neuropeptide Y (NPY) or brain-derived neurotrophic factor (BDNF) can facilitate the emergence of LTP (permissive effect) or function as a molecular switch to initiate biochemical changes during synaptic plasticity.
It would certainly be impertinent to claim an exclusive role of BDNF during such plasticity phenomena; however, there have been a number of studies since the mid 1990s that have documented BDNF as one of the very essential neuromodulators in regulating synaptic plasticity.
BDNF synthesis and processing
The protein BDNF belongs to the family of neurotrophins which are secreted as neurotrophic factors into the extracellular space (other members are NGF, NT-3, and NT-4/5). BDNF regulates a number of biological processes such as the neurogenesis during the development of the central nervous system, the differentiation and survival of neurons, and the regulation of synaptic plasticity in the adult mammalian brain [2, 3] .
Biologically active BDNF consists of a dimer that is constructed from two identical peptide chains held together by noncovalent interactions. In contrast, stable monomeric BDNF could not yet be detected in either the intra-or the extracellular space. As is common for secretory proteins, BDNF is sequestered into the endoplasmic reticulum (ER) as a precursor protein (pre-pro-BDNF, calculated molecular weight (MW) of the monomer: 28 kDa; . Fig. 1 ). The presequence (signaling peptide: 18 AS) is responsible for binding of the BDNF mRNA to the ribosomes of the ER and synthesis of BDNF protein into the endoplasmic reticulum (ER). Inside the ER the presequence is immediately cleaved off the protein. The resulting proBDNF (calculated MW of the monomer: 26 kDa, measured MW by western blot: 32 kDa) is then transported from the ER through the Golgi apparatus to the trans-Golgi-network (TGN), which is the protein distribution station of the cell. In the TGN, it undergoes further processing, which includes glycosylation of amino acids, chemical modification of functional groups of amino acid chains (amidation, acetylation, sulfation), and endoproteolytic cleavage by so-called protein-convertases (PCs), which remove the pro-part from the so-called mature BDNF (matBDNF; calculated MW of the monomer: 13.5 kDa). Finally, the distinguishable vesicles (secretory granules) of the regulated secretory pathway and the constitutive pathway bud off from the TGN. Both types of vesicles can contain proBDNF, as well as its cleaved-off fragments (isolated pro-domain, calculated MW of the monomer: 12.5 kDa) and mature BDNF (. Fig. 1 ). The pH value of the secretory granules is slightly acidic (pH 5.5-6.0), which helps with the tight packing of BDNF and other vesicle contents, e.g., a variety of scaffolding proteins (granines), calcium (10 μM-1 mM), membrane-associated sorting proteins (e.g., sortilin, carboxypeptidase E [CPE]), and the aforementioned PCs (for review see [4] ). During exocytosis, all of these substances are released, although the exact composition of this vesicle cocktail is yet unknown. While it is assumed that proBDNF is the dominant form of BDNF in the Golgi and the TGN, most of it is likely cleaved within the secretory vesicles or during exocytosis (compare [5] ). In addition, extracellular proteases (e.g., plasmin, matrix metalloproteases [MMPs]) can cleave secreted proBDNF to mature BDNF after its release into the extracellular space [4] .
Because proBDNF and matBDNF activate signaling cascades that partially antagonize each other, the importance of knowing the exact identity of the released BDNF (proBDNF dimer vs. matBDNF dimer) can hardly be overstated. While ma-ture BDNF prefers binding to the tyrosine-kinase receptor B (TrkB) and, among other functions, supports LTP and neuronal survival, proBDNF preferably docks to the p75 receptor, which mediates longterm depression (LTD) and apoptosis (. Fig. 1, [6] ). Although the separation between proBDNF/p75 and matBDNF/ TrkB signaling cascades seems to be so clear and strict, it is feasible that there are "soft transitions" between the two extremes, which could be mediated by differences in concentration and pH, for example. In fact, there are indications that matBDNF can interact with p75 homodimers and that p75 and TrkB receptors can associate with each other and, thus, bind matBDNF (. Fig. 1 ). In addition, the TrkB and p75 signaling cascades are complementary and synergistic contributors to the construction and remodeling of synaptic spines (compare [7] ), which are themselves important substrates for synaptic plasticity. Moreover, the exact degree of activation of the different signaling cascades after the exocytosis of proBDNF and matBDNF can potentially be influenced by extracellular proteases (MMP, plasmin). While these various details might add to the complexity of the subject, the interaction of the two different BDNF signaling pathways offers a variety of starting points to fine-tune synaptic plasticity processes.
BDNF expression and transport within the cell
In many brain regions at basal physiological levels in vivo, BDNF is only moderately expressed. Therefore, enzyme-linked secondary antibodies which detect the pro- [9] ). In adult rats and mice, BDNF is best detected in the mossy fiber terminals of the CA3 region of the hippocampus, in the visual and somatosensory cortex, and also in the amygdala. Immunocytochemical investigations with fluorescence-tagged secondary antibodies (excluding the aforementioned signal amplification) confirm this especially conspicuous axonal localization of endogenous BDNF in the hippocampal CA3 region [10] . However, using the same experimental setup, detection of endogenous BDNF in dendrites of the hippocampus is only occasionally possible. It is conceivable that the expression levels of endogenous BDNF in these structures are below the detection threshold of fluorescence-tagged antibodies. Nonetheless, the dendritic localization of BDNF mRNA [11] is a strong indicator for dendritic synthesis and, therefore, is also a strong indicator for the dendritic localization of BDNF protein in pyramidal neurons of the hippocampus and of the cortex [9, 12] . Conversely, the detection of BDNF protein is no proof for the synthesis of this factor in the same brain area: for example, BDNF can reach the striatum, which does not transcribe BDNF mRNA (it mostly contains GABAergic neurons which cannot synthesize BDNF; see below), via anterograde axonal transport from the cortex. In addition, secreted BDNF can be taken up into neurons via receptor-mediated endocytosis and afterwards transported over long distances in the same cell to finally be secreted in a different brain region, which itself cannot synthetize BDNF de novo. Other than in neurons, this reexocytotic mechanism is also known from glia cells and even in the thrombocytes of the blood. Therefore, thrombocytes are able to buffer virtually all of the BDNF in the blood stream (see below). This shows that endocytosis and a subsequent exocytosis are not limited to cells which can synthesize BDNF by themselves. Rather, the only prerequisite for taking the neurotrophin up into the cell and transporting it is the existence of BDNF receptors (p75 and/or TrkB).
Interestingly, only glutamatergic (but not GABAergic) neurons in the CNS possess the ability to synthesize BDNF. However, the survival and presynaptic maturation of GABAergic neurons are especially dependent on the availability of extracellular BDNF ( [13] ; for review see [14] ). It is generally accepted that GABAergic neurons receive their required BDNF at the terminals of inhibitory synapses, which preferentially connect to the somata and proximal dendrites of glutamatergic neurons. Under these circumstances, a somatic and dendritic localization of BDNF seems likely and has unequivocally been proven in cell culture models (. Fig. 2 ; compare [4] ).
In addition, synthesis of the BDNF protein is closely regulated by the electrical activity of glutamatergic neurons; the transcription and the transport of BDNF mRNA into proximal dendrites and the expression of BDNF protein are immensely increased by the electrical activity of glutamatergic neurons (compare [9] ). Thus, when it comes to activity-dependent effects of BDNF on synaptic plasticity, mechanisms which strongly control the expression and secretion of BDNF through electrical cell signaling can play an important role. At this point, such mechanisms have mostly been verified in dendrites, where they are especially effective at facilitating selected synaptic inputs.
Dissociated neuronal cultures that overexpress GFP-tagged BDNF have become an important tool to analyze BDNF transport and secretion in and from glutamatergic neurons in real time. This is currently not possible with only weakly expressed endogenous BDNF. Typically, dissociated cultures show much electrical activity which may be the reason for their prominent-but not exclusivelydendritic expression of BDNF. Examples for anterograde axonal and for dendritic transport could be obtained through this ectopic BDNF-GFP expression (compare [4] ).
Considering previous observations on the axonal and dendritic localization and transport of BDNF, it does not seem reasonable to expect a solely axonal or dendritic transport of BDNF vesicles. Evidently, the actual intracellular localization of BDNF likely depends on the ontogenetic state of development of the brain region that is being investigated, as well as on the state of cellular activity (compare with [9] and . Fig. 2 ).
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Activity-dependent release of BDNF
Two different mechanisms enable the release of BDNF (and other neuropeptides). The vesicles of the constitutive secretion pathway are continuously depleted as soon as they reach the cell membrane. In contrast, the vesicles (secretory granula) of the regulated pathway can release their contents in an activity-dependent fashion, following an intracellular increase of the Ca 2+ concentration (compare [4, 9] ).
Towards the late 1990s, the secretion of endogenous BDNF from brain slices and dissociated cultures was investigated for the first time by utilizing a variety of methods (immunocytochemistry, ELISA, western blot; compare [15] ). However, real-time investigations of BDNF release at the cellular and subcellular levels are currently only possible through overexpression of GFP-tagged BDNF in primary cultures (. Fig. 2 , compare [9] ). Such investigations were first conducted by depolarizing cells for up to 300 s, using an extracellular addition of 50 mM K + . Later, Altogether, these studies show that the kinetics of BDNF secretion are slower than those of neurotransmitters, by a factor of at least 10. In these experiments, the release of the protein can be detected live as a reduction of the intracellular BDNF-GFP fluorescence. It typically continues even after the stimulation. Nevertheless, BDNF-containing vesicles are not depleted completely (. Fig. 3 ). Trains of action potentials at high frequencies (tetanus or theta burst stimulation), which are also efficient at initiating LTP, outmatch trains at lower frequencies which are using the same number of action potentials ( [16] ; compare [14] ). During electrophysiological recordings, the release of BDNF-GFP from cultivated neurons of the hippocampus can either be initiated by backpropagating APs in dendrites or by orthodromic spread of APs in the axon [17, 18] . The influx of calcium into the cell-either via voltage-gated calcium channels (L-type in the dendrite, likely N-, P-and Q-type in the axon; . Fig. 2 ), TRP channels, or NMDA receptors-is causally connected to the exocytosis of BDNF vesicles. The increase of intracellular cAMP and the activity of CaMKII promote the efficiency of dendritic BDNF release without inducing it by themselves (compare [9] ). Because both signaling pathways are closely connected to LTP, the release of BDNF could be a possible connection between the induction and expression of LTP. The dendritic release of BDNF is further supported by Ca 2+ -influx-induced Ca 2+ -mobilization from ryanodine-sensitive intracellular storage compartments (ER; [19] ). This mechanism could be an explanation for the continuous secretion of BDNF beyond the time of the depolarization and the cessation in firing of backpropagating APs, respectively (. Fig. 3 ). In this same regard, all incidents-including Ca 2+ elevations spilling over from neighboring synapses-that lead to a long-lasting increase of Ca 2+ could induce or augment the secretion of BDNF (. Fig. 2 ) and, therefore, initiate the expression of BDNF-dependent plasticity at the corresponding synapses, even during a weak presynaptic stimulation. In this manner, associative synaptic plasticity processes could also be mediated by BDNF.
At the dendrite, secretion of BDNF can take place at both postsynaptic and extrasynaptic structures [20, 21] . It has not yet been resolved whether axonal BDNF secretion can only occur at synaptic boutons or whether it can also take place outside of presynaptic terminals. In any case, both pre-and postsynaptic structures possess the ability to locally fuse BDNF vesicles with the membrane to strengthen the associated synapses after increased electrical activity. However, local BDNF secretion is likely to remain a localized event because BDNF is, due to its chemical properties (very alkaline pI value, i.e. BDNF has a strongly positive charge at the neutral pH of the extracellular space) is extremely "sticky" and therefore binds strongly to the extracellular matrix-a rather interesting property, considering the input specificity of LTP and its biochemical mediation.
In marked contrast to everything we know about the secretion of low-molecular neurotransmitters such as glutamate and GABA, the opening of a fusion pore in a secreting neuropeptide vesicle does not lead to full depletion of its contents. This is due to the special packaging of neuropeptides in general and BDNF especially: the acidic pH value, available Ca 2+ ions, and granines lead to an extremely tight packing (virtually crystalline; [22] ) of the peptide cocktail inside of the vesicle before fusion-pore opening, after which the pH of the vesicle is immediately neutralized (compare [4] ). Because GFP fluorescence is strongly quenched at the typical vesicular pH value of 5.5, the opening of fusion pores can be detected as a flashing up of BDNF-GFP-carrying vesicles (see . Fig. 3c ). From this, as well as from similar investigations with the GFP-quenching agent bromphenol blue, two conclusions can be drawn (see [9] ): 1. Some BDNF vesicles fuse with the cell membrane with considerable delay, many seconds after the start of a depolarization [19, 23] . 2. Even when the fusion pore is open for more than 100 s, not all of the content is released from the fused vesicles.
It is especially the latter property that indicates that the release of the protein can be finely tuned even after opening of the fusion pore through selective dilatation or constriction of the original pore.
Since only the BDNF that in fact reaches the extracellular space can regulate synaptic transmission such a fine tuning of release is inevitably of importance for the forms of synaptic plasticity that are initiated through BDNF.
Effect of BDNF on long-term potentiation of synaptic transmission
As mentioned earlier, BDNF could either change the conditions to facilitate the initiation of LTP (permissive effect) or be a molecular switch for the expression of synaptic plasticity (instructive effect; [24] ). In fact, the constant availability of sufficient extracellular BDNF is essential for the induction of LTP, especially during early postnatal development where it counteracts synaptic fatigue of the glutamate release during tetanic stimulation. Thus, under these circumstances, BDNF acts permissively [25, 26] . Especially concerning the role of BDNF as a mediator (or instructor) for synaptic plasticity, there are a number of indications that show the importance of BDNF release. Investigations on LTP in brain slices of knock-out mice or following blockage of the TrkB signaling pathway in wildtype mice confirm a role of BDNF as a mediator of LTP in the CA1 and CA3 regions of the hippocampus, in layer II/III of the somatosensory cortex, in the perirhinal cortex, in the visual cortex, and in the basolateral amygdala ( [27, 28, 29, 30, 31] ; for an overview see [9, 14] ; . Fig. 5 ). Here, experiments with so-called BDNF scavengers (molecules which selectively bind extracellular BDNF and inactivate it: TrkB-Fc, TrkB-IgG, BDNF antibodies) can be especially insightful: If washing these scavengers into the tissue right before LTP induction results in a selective block of the potentiation, then it can be considered as near certain evidence for the importance of BDNF for the expression of LTP when it is released during the LTP induction (compare . Fig. 4) . However, there is one disadvantage with this approach: Washing a BDNF scavenger in "right before" LTP induction is not possible. The molecules mentioned above have a molecular weight of 60 kDa and can only diffuse slowly into the tissue and the synaptic cleft, where their function-blocking effect is especially important for these experiments. The data mentioned above were, in all cases, obtained by pre-incubating with BDNF scavengers for more than 1 h. However, investigations with photo-activated BDNF antibodies could reduce the time needed for switching on BDNF scavenging at the synapse to only 2 min before LTP induction. These experiments revealed an instructive role of BDNF, at least for the LTP in the CA1 region of the hippocampus [32] . However, what exact synaptic modifications can BDNF cause after secretion during LTP induction? Early studies in the 1990s that were aimed at answering this question were often conducted by adding BDNF exogenously. They showed that in many brain regions the release of presynaptic glutamate and the responsiveness of AMPA and NMDA receptors were increased by BDNF (. Fig. 4 ; for an overview see [14] ). However, because exogenously added BDNF acts nonselectively on all cells of the incubated tissue, it remains to be explained which modification is really conducted by locally secreted endogenous BDNF during the LTP induction. In such a case, experiments with the aforementioned BDNF scavengers can give clarity (for an overview, see [9] ): They confirm that endogenously released BDNF leads to the insertion of AMPA receptors into the postsynaptic membrane within 30 min after the initiation of LTP (. Fig. 5 ). For example, this is true for glutamatergic synapses of layer IV of the somatosensory cortex [27] , and for the glutamatergic, thalamic input of the lateral amygdala [30] .
For glutamatergic mossy fiber inputs of the hippocampal CA3 region and for a strong high frequency tetanic stimulation in the hippocampal CA1 region, BDNF could be shown to lead to a presynaptic expression of LTP (compare [9, 31, 33] ). Mixed pre-and postsynaptically mediated LTP through endogenous BDNF could be detected by means of an elegant inhibition of TrkB receptors in either pre-or postsynaptic neurons of the CA1 region [34] . The bottom line is that BDNF/TrkB signaling pathways can influence early LTP (<2 h; e-LTP) pre-and postsynaptically at many glutamatergic synapses. Which of these two options is eventually implemented might simply depend on the brain region, the state of development of the investigated synapse, and the details of the applied LTP induction protocol.
This picture changes when it comes to late protein-synthesis-dependent LTP (>2 h; l-LTP). High-frequency synaptic activity-patterns in the CA1 region of the hippocampus, during which e-LTP can be expressed independently of BDNF, do indeed show l-LTP that is dependent on BDNF [35, 36] . The application of exogenous BDNF several hours after LTP induction can even rescue l-LTP if it has been blocked by inhibitors of protein biosynthesis. These data speak in favor of a requirement for a "second wave" of de novo synthesis and a release of BDNF about 1-2 h after the induction of LTP under physiological in vivo circumstances (compare section above), and for BDNF as a major component of l-LTP expression (compare [9] ). The substrate for the BDNF-effect for long-lasting storage of synaptic information in a Hebbian sense could be the growth of spines, which is strongly promoted by BDNF [7, 37, 38] .
The fact that GABAergic synapses also show LTP and are supplied with BDNF that is released from postsynaptic glutamatergic neurons (compare above) raises the question of a mechanism for a BDNF-dependent LTP at these synapses. Exogenous and endogenous application of BDNF as well as a chronically insufficient supply with the neurotrophin (e.g., in BDNF knock-out mice) reveal pre-as well as postsynaptic changes in GABAergic synapses (. Fig. 5 ). Exogenous BDNF increases the formation of GABAergic synaptic boutons and leads to a short-term rise in GABA release at already active synaptic terminals, but then switches to the opposite effect after only a few minutes (for an overview see [14] ). At the postsynaptic site, BDNF first promotes the efficiency of GABAergic synapses, only to lead to the endocytosis of GABA A receptors and the weakening of the inhibition several minutes later. In case of a chronic shortage of BDNF in BDNF knock-out mice, a reduction in the number of GABAergic boutons during ontogenesis leads to an overall weakening of synaptic inhibition [39] .
The exact way in which endogenously released BDNF influences GABAergic synaptic transmission is of further physiological importance for inhibitory synapses. Interestingly, after a depolarization-induced BDNF release from postsynaptic, glutamatergic neurons, GABAergic synapses show an increase in synaptic efficiency during transmission ( [40, 41] ; for review see [14] , . Fig. 5 ). Similar investigations prove that LTP at mossy fiber inputs of the CA3 region of the hippocampus is dependent on BDNF at an early postnatal stage, at times when these synapses are still GABAergic [42, 43] . Altogether, acutely secreted BDNF leads to a short-term increase in the functionality of GABAergic synapses while long-term availability of BDNF positively regulates the number of GABAergic terminals.
Role of BDNF in neurodegenerative diseases and psychological disorders
Because BDNF regulates synaptic plasticity in many brain regions, and since this [46] and that about 75% of the BDNF in the blood plasma arises from the brain [47, 48] . Even though T-and B-lymphocytes and monocytes can synthesize and release BDNF, their effect on the BDNF content in the blood is minor [49] . Interestingly, although thrombocytes are not capable of synthesizing BDNF they can store it especially well. Presumably, they can take up BDNF via receptor-mediated endocytosis and deplete their BDNF stores during blood clotting or in response to substances that stimulate secretion [50, 51] . In this way, thrombocytes form an efficient buffer system for BDNF in the blood. The BDNF that can be detected in the blood serum after clotting is derived from these blood cells by at least 95%. Because the pituitary gland [52] and endothelial cells of the blood vessels [53] can also synthesize and release BDNF (compare . Fig. 2 ), all these structures most likely take part in producing the BDNF content in the blood stream at any given time.
As complicated as the connections between the different BDNF-synthesizing and -secreting cells in the brain and in the blood may seem, the changes in BDNF content in the blood in association with some neurological disorders are just as obvious. In this regard, it could be shown that the BDNF concentration in the blood serum is especially low in untreated depressive patients, but returns to normal levels after successful treatment. Furthermore, antidepressants have clearly been shown to influence the neuronal TrkB signal transduction in animal experiments [54] .
At this point, further studies also indicate that there is a correlation between low BDNF levels in blood and the severity of Alzheimer's disease in dementia patients [55] . In addition, BDNF levels have been shown to possess prognostic relevance for bipolar disorders. However, a clear causal connection between reduced BDNF transport, disrupted TrkB signaling pathways in the striatum, and the onset of the disease could only be shown for Huntington's disease (compare . Fig. 6 ).
In Europe, about 30% of the population is heterozygous and 5% is homozygous for a single-nucleotide polymorphism of the BDNF gene, in which the exchange of a single amino acid (Val66 → Met) in the prodomain of BDNF leads to a reduced secretion of BDNF ( [56] ; for review see [4] ). A number of studies have attempted to show a positive correlation between this polymorphism and a reduction of memory function, as well as the appearance of dementia, depression, and schizophrenia. However, there is no clear proof for such a correlation at this point. In any event, humans are not helpless victims of their BDNF genes and its translation into a well releasable protein: many studies on rodents and humans have doubtlessly proven that endurance sports are an efficient way to increase BDNF levels in the brain and the blood [57] . Not only does electrical activity in neurons increase the expression of BDNF, but physical activity in the muscles-mediated through factors that can cross the blood-brain barrier (IGF-1 and VEGF)-also increase the availability of BDNF in the brain and can, therefore, counteract a much too early decline of our memory.
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